Alkem Laboratories Legal & Regulatory
Alkem Laboratories received favorable CIT(A) orders for assessment years 2018-2023. The ruling deletes tax disallowances totaling Rs. 660.77 Crore, providing significant regulatory relief.
- Value
- ₹660.8 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Alkem Laboratories received favorable CIT(A) orders for assessment years 2018-2023. The ruling deletes tax disallowances totaling Rs. 660.77 Crore, providing significant regulatory relief.
Alkem Laboratories received favourable tax orders from CIT(A) for AY 2018-2023. The orders involve a tax amount of ₹60.77 Crore.
Alkem Laboratories Limited received a favorable order dropping a GST demand of ₹69.66 Crore, including interest and penalties. The order from Mumbai GST authorities relates to alleged incorrect ITC/refund claims. The company stated there is no material impact on its financial or operational activities.
Alkem Laboratories received an income tax assessment order for AY 2023-24 with a disputed tax amount of ₹333.38 Crore. The dispute relates to 80IE deduction disallowance and transfer pricing adjustments. The company states no cash outflow is expected due to MAT credit utilization and plans to appeal the order.